BMY Bristol-Myers Squibb Company
Healthcare
Price
$63.65
Intrinsic value
$27.82
Buy price
$22.26
Discount
-128.8%
DCF walkthrough
Near-term growth (g1)1.45%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
- Operating CF
- $12,782,000,000.00
- Total debt
- $45,053,001,728.00
- Cash & STI
- $11,066,999,808.00
- Shares out.
- 2,048,000,000
Overvalued
Intrinsic value$27.82
Buy price (with MOS)$22.25
Current price$63.65
Discount to intrinsic value-128.8%
7-step quality scorecard
ROE quality
LOW- Average ROE
- 7.8%
- Current ROE
- 38.2%
- Minimum ROE
- -54.8%
Debt quality
LEVERAGED- Debt / Equity
- 2.44x
Moat proxy
MODERATE_PROXYCash-flow reliability
OK- Operating CF / Net income
- 1.38x
Technical chart
Confluence: NONE (0/3)Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim.
Assumptions & data quality
- Data source
- yfinance
- Growth (g1) source
- min(revenueCAGR,cfCAGR)
- Valuation model
- DCF_OCF
- Debt as % of DCF PV
- 49.5%
- Public economic interest
- 99.8%
These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.